Alzheimer Disease
Showing NaN - NaN of 37
Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)
Recruiting
- Alzheimer Disease
- +2 more
- JNJ-63733657
- Placebo
-
Birmingham, Alabama
- +143 more
Jan 31, 2023
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Enrolling by invitation
- Diabetes
- +4 more
-
Phoenix, Arizona
- +26 more
Jan 19, 2023
Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)
Active, not recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
-
Fullerton, California
- +30 more
Jan 18, 2023
Alzheimer Trial in Worldwide (LY3372689, Placebo)
Active, not recruiting
- Alzheimer Disease
- LY3372689
- Placebo
-
Canoga Park, California
- +70 more
Jan 18, 2023
Traumatic Brain Injury, Alzheimer, Veterans Trial in Indianapolis (ABC ANSWERS, Control)
Active, not recruiting
- Traumatic Brain Injury
- +5 more
- ABC ANSWERS
- Control
-
Indianapolis, IndianaRichard L. Roudebush VAMC
Jul 20, 2022
Alzheimer, Dementia, Brain Diseases Trial in Canada, United States (No Intervention, donanemab)
Active, not recruiting
- Alzheimer Disease
- +4 more
- No Intervention
- donanemab
-
Phoenix, Arizona
- +27 more
May 25, 2022
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Recruiting
- Early Onset Alzheimer Disease
- +2 more
- Flortaucipir
- +2 more
-
Sun City, Arizona
- +18 more
Mar 15, 2022
Alzheimer Trial in Indianapolis (UPLIFT-AD)
Recruiting
- Alzheimer Disease
- UPLIFT-AD
-
Indianapolis, IndianaAmerican Senior Communities
Mar 8, 2022
Alzheimer, Mild Cognitive Impairment Trial in Indianapolis, Boston, Jamaica Plain (Pramlintide challenge test)
Recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Pramlintide challenge test
-
Indianapolis, Indiana
- +2 more
Jan 27, 2022
Late Onset Alzheimer's Disease
Recruiting
- Alzheimer Disease
- Blood Draw
- Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
-
Washington, District of Columbia
- +11 more
Aug 11, 2021
Dementia, Dementia, Vascular, Dementia With Lewy Bodies Trial in United States (ADRD-PC Program)
Enrolling by invitation
- Dementia
- +7 more
- ADRD-PC Program
-
Denver, Colorado
- +3 more
Jul 29, 2021
Alzheimer Trial in United States (CAD106)
Completed
- Alzheimer Disease
- CAD106
-
Costa Mesa, California
- +7 more
Dec 11, 2020
Alzheimer Trial in Canada, United States (Placebo Control, ELND005)
Alzheimer Trial in United States (Crenezumab dose level 1, Crenezumab dose level 2, Crenezumb dose level 3)
Completed
- Alzheimer Disease
- Crenezumab dose level 1
- +3 more
-
Phoenix, Arizona
- +12 more
Jul 23, 2019
Alzheimer Trial in Worldwide (Placebo, BI 409306, Donepezil)
Completed
- Alzheimer Disease
- Placebo
- +2 more
-
Sherman Oaks, California
- +59 more
Oct 18, 2018